COVID-19: Healthcare Workers May Be at Greater Risk Outside Their Work Environment-A Retrospective Observational Study.
Journal
Rambam Maimonides medical journal
ISSN: 2076-9172
Titre abrégé: Rambam Maimonides Med J
Pays: Israel
ID NLM: 101538065
Informations de publication
Date de publication:
26 Apr 2022
26 Apr 2022
Historique:
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary medical center before first BNT162b2 vaccination. This was a retrospective observational study. Before vaccination, HCW at our center were offered serological testing. Data on their epidemiological, workplace, and quarantine history were collected. The SARS-CoV-2 IgG assay was performed pre-vaccination. A total of 4,519 (82.5%) of the HCW were tested. Of these, 210 were seropositive; 101 had no known history of COVID-19. Of the 101 asymptomatic HCW, only 3 (3%) had worked at COVID-19 departments, and 70 (69.3%) had not been previously quarantined. Positive serology was similarly distributed across age groups, and about 40% had no children. Nearly half of the HCW tested were administrative and service staff. Overall, seropositive tests were associated with having no children (OR 1.42, 95% CI 1.06-1.89; P=0.0218), history of having been quarantined without proof of disease (OR 6.04, 95% CI 4.55-8.01; P<0.001), and Arab ethnicity (OR 3.36, 95% CI 2.54-4.43; P<0.001). Seropositivity was also more prevalent in members of the administration compared to other sectors, medical and paramedical, who are exposed to patients in their daily work (OR 1.365, 95% CI 1.02-1.82; P=0.04). The low percentage of asymptomatic COVID-19 among our HCW may reflect the high compliance to personal protective equipment use despite treating hundreds of COVID-19 patients. The relatively high number of childless seropositive HCW could reflect misconceptions regarding children as a main source of infection, leading to carelessness regarding the need for appropriate out-of-hospital protection.
Sections du résumé
BACKGROUND
BACKGROUND
With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary medical center before first BNT162b2 vaccination.
METHODS
METHODS
This was a retrospective observational study. Before vaccination, HCW at our center were offered serological testing. Data on their epidemiological, workplace, and quarantine history were collected. The SARS-CoV-2 IgG assay was performed pre-vaccination.
RESULTS
RESULTS
A total of 4,519 (82.5%) of the HCW were tested. Of these, 210 were seropositive; 101 had no known history of COVID-19. Of the 101 asymptomatic HCW, only 3 (3%) had worked at COVID-19 departments, and 70 (69.3%) had not been previously quarantined. Positive serology was similarly distributed across age groups, and about 40% had no children. Nearly half of the HCW tested were administrative and service staff. Overall, seropositive tests were associated with having no children (OR 1.42, 95% CI 1.06-1.89; P=0.0218), history of having been quarantined without proof of disease (OR 6.04, 95% CI 4.55-8.01; P<0.001), and Arab ethnicity (OR 3.36, 95% CI 2.54-4.43; P<0.001). Seropositivity was also more prevalent in members of the administration compared to other sectors, medical and paramedical, who are exposed to patients in their daily work (OR 1.365, 95% CI 1.02-1.82; P=0.04).
CONCLUSIONS
CONCLUSIONS
The low percentage of asymptomatic COVID-19 among our HCW may reflect the high compliance to personal protective equipment use despite treating hundreds of COVID-19 patients. The relatively high number of childless seropositive HCW could reflect misconceptions regarding children as a main source of infection, leading to carelessness regarding the need for appropriate out-of-hospital protection.
Identifiants
pubmed: 35482461
pii: RMMJ.10469
doi: 10.5041/RMMJ.10469
pmc: PMC9049148
doi:
Types de publication
Journal Article
Langues
eng
Références
Asia Pac J Public Health. 2021 Jan;33(1):126-128
pubmed: 33242979
Thorax. 2020 Dec;75(12):1089-1094
pubmed: 32917840
Int J Infect Dis. 2021 Jan;102:239-241
pubmed: 33130210
Indian J Med Res. 2021 Jan & Feb;153(1 & 2):207-213
pubmed: 33642348
BMJ Open. 2021 Mar 2;11(3):e045598
pubmed: 33653763
Infect Control Hosp Epidemiol. 2021 Feb;42(2):212-214
pubmed: 32746953
Infection. 2020 Aug;48(4):631-634
pubmed: 32524515
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec 18;:
pubmed: 33485676
Int J Infect Dis. 2021 Jan;102:136-143
pubmed: 33075538
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1221-1226
pubmed: 32881855
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510